Updated:
WRQ Sciences
WRQ Sciences is a Palo Alto-based venture capital firm founded in 2022 to invest in early-stage startups combining biology and computation.
WRQ Sciences
WRQ Sciences was founded in 2022 and operates from Palo Alto, California. The firm deploys capital into US-based startups at the earliest stages, where technological risk is most acute and downstream returns are highest. Its formation reflects a broader trend of scientist-investors building dedicated vehicles rather than joining multi-sector platforms. The firm targets companies operating where computational methods meet biological discovery — a mandate spanning drug discovery platforms, synthetic biology tools, diagnostics, and biology-first enterprise software. WRQ Sciences executes via equity investments in seed and Series A rounds, typically as a lead or co-lead. The fund's geographic focus is domestic, though its portfolio companies often serve global pharmaceutical and agricultural supply chains. WRQ Sciences maintains a deliberately lean structure appropriate for a young, thesis-driven fund. Team size, total committed capital, and specific portfolio holdings are not publicly disclosed. The firm has no known philanthropic vehicles, operating subsidiaries, or co-investor clubs at this stage. In an environment where many life-science funds oversubscribe and spread thin, WRQ Sciences' early positioning suggests a commitment to portfolio concentration. What distinguishes WRQ Sciences is its sector purity. Unlike diversified seed funds that treat biotech as an allocation, the firm was purpose-built for a single domain. That architecture allows general partners to underwrite technical milestones — IND filings, laboratory reproducibility, algorithmic specificity — with the same fluency as the founders they back.
General information
Firm type
Private Equity
Year founded
2022
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Palo Alto
Corporate office
Palo Alto, CA, United States
Sector focus
Frequently asked questions
What is WRQ Sciences' investment thesis?
WRQ Sciences invests in early-stage US startups where computational approaches drive biological discovery. The firm looks for teams building proprietary datasets, novel algorithms, or laboratory automation that can compress the timeline from hypothesis to validated therapeutic or diagnostic candidate.
Does WRQ Sciences lead rounds or participate as a co-investor?
The firm's early-stage mandate and small fund size are consistent with leading or co-leading seed and Series A rounds. Lead-investor posture gives WRQ Sciences board seats and influence over syndicate construction, though specific portfolio-company governance details remain private.
How does WRQ Sciences source deals?
Given its Palo Alto location and domain specificity, deal flow likely originates from academic spinouts at Stanford, UCSF, and the broader Bay Area research ecosystem, as well as from incubators and founder referrals within computational biology networks.
Is WRQ Sciences a single-family office or a traditional venture fund?
WRQ Sciences is structured as an asset manager raising external limited-partner capital, not a single-family office. The firm operates a blind-pool venture fund targeting institutional and high-net-worth investors rather than managing a single family's wealth.
What is the fund's known deployment pace?
Total commitments and deployment figures are not publicly disclosed. Given the 2022 vintage year and standard investment periods of three to four years for early-stage venture funds, the firm is likely still in its active deployment window.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: